Mark J. Pykett
2010
In 2010, Mark J. Pykett earned a total compensation of $772.6K as Chief Executive Officer at Navidea Biopharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $6,278 |
|---|---|
| Option Awards | $193,783 |
| Salary | $41,875 |
| Stock Awards | $530,700 |
| Total | $772,636 |
Pykett received $530.7K in stock awards, accounting for 69% of the total pay in 2010.
Pykett also received $6.3K in non-equity incentive plan, $193.8K in option awards and $41.9K in salary.
Rankings
In 2010, Mark J. Pykett's compensation ranked 6,213th out of 10,439 executives tracked by ExecPay. In other words, Pykett earned more than 40.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,213 out of 10,439 | 41st |
Division Manufacturing | 2,236 out of 3,838 | 42nd |
Major group Chemicals And Allied Products | 496 out of 926 | 46th |
Industry group Drugs | 310 out of 685 | 55th |
Industry In Vitro and In Vivo Diagnostic Substances | 18 out of 51 | 65th |
Source: SEC filing on May 24, 2013.
Pykett's colleagues
We found four more compensation records of executives who worked with Mark J. Pykett at Navidea Biopharmaceuticals in 2010.
2010
David Bupp
Navidea Biopharmaceuticals
Chief Executive Officer
2010
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2010
Brent Larson
Navidea Biopharmaceuticals
Chief Financial Officer
2010
Rodger Brown
Navidea Biopharmaceuticals